HRP high-grade serous carcinomas are molecularly heterogeneous; a lead candidate for negative predictive testing is the presence of high-level amplifications of CCNE1 given its mutual exclusivity to BRCA1/2 germline mutations as shown by Bowtell and colleagues [64,65,76]. Here, BRCA1 is linked to serous adenocarcinoma.